跳至主要内容
临床试验/CTRI/2022/04/042311
CTRI/2022/04/042311暂停3 期

Efficacy of BCG revaccination compared with oral chemoprophylaxis in household contacts aged 6-18 years for prevention of Tuberculosis disease – A phase III open labelled randomised control trial.

ICMRNIRT0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy household contacts aged > 5 to 18 years
  • 2. Previously vaccinated with BCG at birth or least 5 years ago - evidence of scar or documented immunisation record.
  • 3. General good health – through history and baseline screening
  • 4. Agrees to continue in the study for 2 years post enrollment
  • 5. Children previously treated for LTBI and completed treatment at least 6 months ago - can also be included. However, they should be current HHC

排除标准

  • 1.Any acute illness on recruitment day (Evaluate the child again at a later stage)
  • 2.Fever =38 degree Celsius on recruitment day (Evaluate the child again at a later)
  • 3.History / presence of autoimmune disease
  • 4.Pregnancy – female participants > 15 years of age will have pregnancy test done after caretakers and participants informed consent
  • 5.Evidence of active TB disease
  • 6.On treatment for active TB disease or LTBI
  • 7.HIV positive
  • 8.Any history or present possible immunodeficiency condition
  • 9.History of administration of immunoglobulins/immunotherapy/immune-suppressants/blood products in the preceding 3 months or planned administration during the study period
  • 10.History of allergic reactions to vaccines in past
  • 11.History of severe adverse reactions to primary BCG
  • 12.Pre-existing liver dysfunction
  • 13.ALT/AST is = 3 times upper limit of normal (ULN) in the presence of symptoms or = 5 times the ULN in the absence of symptoms and/or total bilirubin greater than ULN along with raised ALT/AST.
  • 14.History of previous administration of newer/trial TB vaccines
  • 15. Participation in other clinical trials in preceding 3 months or planned / concurrent participation
  • 16.History of chronic renal failure, malignancy, transplants (cardiac/renal/liver), inflammatory or metabolic conditions, neurological/seizure/psychiatric disorders – issues that make participant unlikely to volunteer

研究者

发起方
ICMRNIRT

相似试验